Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia

Chun Jen Hsiao, Tzong Shin Tzai, Chein Hung Chen, Wen Horng Yang, Chung Hsuan Chen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Glycans of prostate-specific antigen (PSA) in prostate cancer were found to be different from that in benign disease. It is difficult to analyze heterogeneous PSA glycoforms in each individual specimen because of low protein abundance and the limitation of detection sensitivity. We developed a method for prostate cancer diagnosis based on PSA glycoforms. Specific glycoforms were screened in each clinical sample based on liquid chromatography-tandem mass spectrometry with ion accumulation. To look for potential biomarkers, normalized abundance of each glycoform in benign prostate hyperplasia (BPH) and in prostate cancer was evaluated. The PSA glycoform, Hex5HexNAc4NeuAc1dHex1, and monosialylated, sialylated, and unfucosylated glycoforms differed significantly between the prostate cancer and BPH samples. The detection sensitivity (87.5%) and specificity (60%) for prostate cancer identification are higher than those of the serum PSA marker. As low as 100 amol PSA could be detected with the ion accumulation method which has not been reported before. The improved detection specificity can help reduce unnecessary examinations.

Original languageEnglish
Article number8915809
JournalDisease Markers
Volume2016
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Prostate-Specific Antigen
Hyperplasia
Prostatic Neoplasms
Ions
Liquid chromatography
Biomarkers
Tandem Mass Spectrometry
Liquid Chromatography
Mass spectrometry
Polysaccharides
Prostate
Sensitivity and Specificity
Serum
Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Hsiao, Chun Jen ; Tzai, Tzong Shin ; Chen, Chein Hung ; Yang, Wen Horng ; Chen, Chung Hsuan. / Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia. In: Disease Markers. 2016 ; Vol. 2016.
@article{efd90dc3041442f6a200e972c52c66b3,
title = "Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia",
abstract = "Glycans of prostate-specific antigen (PSA) in prostate cancer were found to be different from that in benign disease. It is difficult to analyze heterogeneous PSA glycoforms in each individual specimen because of low protein abundance and the limitation of detection sensitivity. We developed a method for prostate cancer diagnosis based on PSA glycoforms. Specific glycoforms were screened in each clinical sample based on liquid chromatography-tandem mass spectrometry with ion accumulation. To look for potential biomarkers, normalized abundance of each glycoform in benign prostate hyperplasia (BPH) and in prostate cancer was evaluated. The PSA glycoform, Hex5HexNAc4NeuAc1dHex1, and monosialylated, sialylated, and unfucosylated glycoforms differed significantly between the prostate cancer and BPH samples. The detection sensitivity (87.5{\%}) and specificity (60{\%}) for prostate cancer identification are higher than those of the serum PSA marker. As low as 100 amol PSA could be detected with the ion accumulation method which has not been reported before. The improved detection specificity can help reduce unnecessary examinations.",
author = "Hsiao, {Chun Jen} and Tzai, {Tzong Shin} and Chen, {Chein Hung} and Yang, {Wen Horng} and Chen, {Chung Hsuan}",
year = "2016",
month = "1",
day = "1",
doi = "10.1155/2016/8915809",
language = "English",
volume = "2016",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",

}

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia. / Hsiao, Chun Jen; Tzai, Tzong Shin; Chen, Chein Hung; Yang, Wen Horng; Chen, Chung Hsuan.

In: Disease Markers, Vol. 2016, 8915809, 01.01.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia

AU - Hsiao, Chun Jen

AU - Tzai, Tzong Shin

AU - Chen, Chein Hung

AU - Yang, Wen Horng

AU - Chen, Chung Hsuan

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Glycans of prostate-specific antigen (PSA) in prostate cancer were found to be different from that in benign disease. It is difficult to analyze heterogeneous PSA glycoforms in each individual specimen because of low protein abundance and the limitation of detection sensitivity. We developed a method for prostate cancer diagnosis based on PSA glycoforms. Specific glycoforms were screened in each clinical sample based on liquid chromatography-tandem mass spectrometry with ion accumulation. To look for potential biomarkers, normalized abundance of each glycoform in benign prostate hyperplasia (BPH) and in prostate cancer was evaluated. The PSA glycoform, Hex5HexNAc4NeuAc1dHex1, and monosialylated, sialylated, and unfucosylated glycoforms differed significantly between the prostate cancer and BPH samples. The detection sensitivity (87.5%) and specificity (60%) for prostate cancer identification are higher than those of the serum PSA marker. As low as 100 amol PSA could be detected with the ion accumulation method which has not been reported before. The improved detection specificity can help reduce unnecessary examinations.

AB - Glycans of prostate-specific antigen (PSA) in prostate cancer were found to be different from that in benign disease. It is difficult to analyze heterogeneous PSA glycoforms in each individual specimen because of low protein abundance and the limitation of detection sensitivity. We developed a method for prostate cancer diagnosis based on PSA glycoforms. Specific glycoforms were screened in each clinical sample based on liquid chromatography-tandem mass spectrometry with ion accumulation. To look for potential biomarkers, normalized abundance of each glycoform in benign prostate hyperplasia (BPH) and in prostate cancer was evaluated. The PSA glycoform, Hex5HexNAc4NeuAc1dHex1, and monosialylated, sialylated, and unfucosylated glycoforms differed significantly between the prostate cancer and BPH samples. The detection sensitivity (87.5%) and specificity (60%) for prostate cancer identification are higher than those of the serum PSA marker. As low as 100 amol PSA could be detected with the ion accumulation method which has not been reported before. The improved detection specificity can help reduce unnecessary examinations.

UR - http://www.scopus.com/inward/record.url?scp=84962703912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962703912&partnerID=8YFLogxK

U2 - 10.1155/2016/8915809

DO - 10.1155/2016/8915809

M3 - Article

C2 - 27065039

AN - SCOPUS:84962703912

VL - 2016

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

M1 - 8915809

ER -